These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31684108)

  • 1. Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer.
    Huang YM; Cheng CH; Pan SL; Yang PM; Lin DY; Lee KH
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein 90 is involved in the regulation of HMGA2-driven growth and epithelial-to-mesenchymal transition of colorectal cancer cells.
    Kao CY; Yang PM; Wu MH; Huang CC; Lee YC; Lee KH
    PeerJ; 2016; 4():e1683. PubMed ID: 26893968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.
    Esmailzadeh S; Mansoori B; Mohammadi A; Shanehbandi D; Baradaran B
    J Gastrointest Cancer; 2017 Jun; 48(2):156-163. PubMed ID: 27629422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
    Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
    Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the Effects of Aspirin and Sulindac Sulfide on the Inhibition of HMGA2-Mediated Oncogenic Capacities in Colorectal Cancer.
    Ekanem TI; Tsai WL; Lin YH; Tan WQ; Chang HY; Huang TC; Chen HY; Lee KH
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32842685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
    Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
    J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
    Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
    Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of multiple oncogenic signaling pathways by Hsp90 inhibitor alone or in combination with berberine for treatment of colorectal cancer.
    Su YH; Tang WC; Cheng YW; Sia P; Huang CC; Lee YC; Jiang HY; Wu MH; Lai IL; Lee JW; Lee KH
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2261-72. PubMed ID: 25982393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of HMGA2 by the pan-deacetylase inhibitor panobinostat is dependent on hsa-let-7b expression in liver cancer cell lines.
    Di Fazio P; Montalbano R; Neureiter D; Alinger B; Schmidt A; Merkel AL; Quint K; Ocker M
    Exp Cell Res; 2012 Sep; 318(15):1832-43. PubMed ID: 22683924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer.
    Zhou J; Zhang L; Wang M; Zhou L; Feng X; Yu L; Lan J; Gao W; Zhang C; Bu Y; Huang C; Zhang H; Lei Y
    Theranostics; 2019; 9(19):5577-5594. PubMed ID: 31534504
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer.
    Qi J; Zhou N; Li L; Mo S; Zhou Y; Deng Y; Chen T; Shan C; Chen Q; Lu B
    Cell Death Dis; 2020 Jul; 11(7):582. PubMed ID: 32719342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells.
    Zhang ZC; Wang GP; Yin LM; Li M; Wu LL
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6793-6800. PubMed ID: 30402842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological role of HMGA2 (Review).
    Zhang S; Mo Q; Wang X
    Int J Oncol; 2019 Oct; 55(4):775-788. PubMed ID: 31432151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
    Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
    Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
    Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F
    Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
    Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclopirox targets cellular bioenergetics and activates ER stress to induce apoptosis in non-small cell lung cancer cells.
    Lu J; Li Y; Gong S; Wang J; Lu X; Jin Q; Lu B; Chen Q
    Cell Commun Signal; 2022 Mar; 20(1):37. PubMed ID: 35331268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.
    Unachukwu U; Chada K; D'Armiento J
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reposition of the Fungicide Ciclopirox for Cancer Treatment.
    Huang Z; Huang S
    Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.